Acute and chronic effects of troglitazone [CS-045) on isolated rat ventricular cardiomyocytes

Diabetologia

Volumn 39, Issue 7, 1996, Pages 766-774

  Bahr M ^a   Spelleken, M ^a   Bock, M ^a   Von Holtey, M ^a   Kiehn, R ^b   Eckel, J ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b Sankyo Europe GmbH   (Germany)

Author keywords

Cardiomyocytes; Cell culture; Glucose transport; Protein kinase C; Troglitazone (CS 045)

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE TRANSPORTER; PHORBOL ESTER; PROTEIN KINASE C; TROGLITAZONE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEART VENTRICLE WALL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

3-O-METHYLGLUCOSE; ANIMALS; CELLS, CULTURED; CHROMANS; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; HEART VENTRICLES; HYPOGLYCEMIC AGENTS; IMMUNE SERA; IMMUNOBLOTTING; ISOENZYMES; LACTIC ACID; MALE; MEMBRANE PROTEINS; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MYOCARDIUM; PROTEIN KINASE C; RATS; RATS, WISTAR; TETRADECANOYLPHORBOL ACETATE; THIAZOLES; THIAZOLIDINEDIONES; TIME FACTORS;

EID: 0029896904     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050509     Document Type: Article

References (40)

1. Yoshioka T, Fujita T, Kanai T, Aizawa Y, Kurumada T, Hasegawa K (1989) Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation. J Med Chem 32: 421-428
2. Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H (1988) Characterization of new oral antidiabetic agent CS-045: studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 37: 1549-1558
3. Fujiwara T, Wada M, Fukuda K et al. (1991) Characterization of CS-045, a new oral antidiabetic agent. II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice. Metabolism 40: 1213-1218
4. Lee M-K, Miles PDG, Khoursheed M, Gao K-M, Moossa AR, Olefsky JM (1994) Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes 43: 1435-1439
5. Yoshioka S, Nishino H, Shiraki T et al. (1993) Antihypertensive effects of CS-045 treatment in obese Zucker rats. Metabolism 42: 75-80
6. Suter S, Nolan JJ, Wallance P, Gumbiner B, Olefsky JM (1992) Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care 15: 193-203
7. Mimura K, Umeda F, Hiramatsu S et al. (1994) Effects of a new oral hypoglycemic agent (CS-045) on metabolic abnormalities and insulin resistance in type 2 diabetes. Diabet Med 11: 685-691
8. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J (1994) Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331: 1188-1193
9. Kellerer M, Kroder G, Tippmer S et al. (1994) Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts. Diabetes 43: 447-453
10. Ciaraldi TP, Gilmore A, Olefsky JM, Goldberg M, Heidenreich KA (1990) In vitro studies on the action of CS-045, a new antidiabetic agent. Metabolism 39: 1056-1062
11. Murano K, Inoue Y, Emoto M, Kaku K, Kaneko T (1994) CS-045, a new oral antidiabetic agent, stimulates fructose2,6-bisphosphate production in rat hepatocytes. Eur J Pharmacol 254: 257-262
12. Bader S, Kiehn R, Häring HU (1993) Effect of CS-045 on the activity of insulin-receptor kinase in the skeletal muscle of insulin-resistant Zucker rats. Diabetes und Stoffwechsel 2: 55-61
13. Kobayashi M, Iwanishi M, Egawa K, Shigeta Y (1992) Pioglitazone increases insulin sensitivity by activating insulin receptor kinase. Diabetes 41: 476-483
14. Tafuri SR (1994) Troglitazone stimulates glucose uptake in 3T3-L1 adipocytes. Diabetes 43 [Suppl 1]: 761 (Abstract)
15. Götzsche O (1986) Myocardial cell dysfunction in diabetes mellitus. Diabetes 35:1158-1162
16. Russ M, Eckel J (1995) Insulin action on cardiac glucose transport: studies on the role of protein kinase C. Biochim Biophys Acta 1265: 73-78
17. Eckel J, Asskamp B, Reinauer H (1991) Induction of insulin resistance in primary cultured adult cardiomyocytes. Endocrinology 129: 345-352
18. Bähr M, von Holtey M, Müller G, Eckel J (1995) Direct Stimulation of myocardial glucose transport and glucose transport-1 (GLUT1) and GLUT4 protein expression by the sulfonylurea glimepiride. Endocrinology 136: 2547-2553
19. Eckel J, Pandalis G, Reinauer H (1983) Insulin action on glucose transport system in isolated cardiocytes from adult rat. Biochem J 21: 385-392
20. Hohorst HU (1963) Enzymatic determination of L-(+)-lactate. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press. New York, pp 266-270
21. Kolter T, Uphues I, Wichelhaus A, Reinauer H, Eckel J (1992) Contraction-induced translocation of the glucose transporter GLUT4 in isolated ventricular cardiomyocytes. Biochem Biophys Res Commun 189: 1207-1214
22. Wichelhaus A, Russ M, Petersen S, Eckel J (1994) G protein expression and adenylate cyclase regulation in ventricular cardiomyocytes from STZ-diabetic rats. Am J Physiol 267: H548-H555
23. Takayama S, White MF, Kahn CR (1988) Phorbolester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. J Biol Chem 263: 3440-3447
24. Rybin VO, Steinberg SF (1994) Protein kinase C isoform expression and regulation in the developing heart. Circ Res 74: 299-309
25. Puceat M, Hilal-Dandan R, Strulovici B, Brunton LL, Brown JH (1994) Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes. J Biol Chem 269: 16938-16944
26. Slieker LJ, Sundell KL, Bush KA, Sage SW, Fitch L, Schmiegel K (1994) Thiazolidinediones stimulate 2-deoxyglucose uptake into G9 myocytes secondary to inhibition of oxidative phosphorylation. Diabetes 43 [Suppl 1]: 399 (Abstract)
27. Häring HU, Mehnert H (1993) Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle. Diabetologia 36: 176-182
28. Takino H, Okuno S, Uotani S et al. (1994) Increased insulin responsiveness after CS-045 treatment in diabetes associated with Werner's syndrome. Diabetes Res Clin Pract 24: 167-172
29. Ohsumi J, Sakakibara S, Yamaguchi J et al. (1994) Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells. Endocrinology 135: 2279-2282
30. Takayama S, White MF, Lauris V, Kahn CR (1984) Phorbol ester modulate insulin receptor phosphorylation and insulin action in cultured hepatoma cells. Proc Natl Acad Sci USA 81: 7797-7801
31. m of the ATP-binding site of the insulin receptor kinase from rat adipocytes. J Biol Chem 261: 3869-3875
32. Chin JE, Liu F, Roth RA (1994) Activation of protein kinase C alpha inhibits insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1. Mol Endo 8: 51-58
33. Draznin B, Leitner JW, Sussman KE, Sherman NA (1988) Insulin and glucose modulate protein kinase C activity in rat adipocytes. Biochem Biophys Res Commun 156: 570-575
34. Farese RV, Standaert ML, Francois AJ et al. (1992) Effects of insulin and phorbol esters on subcellular distribution of protein kinase C isoforms in rat adipocytes. Biochem J 288: 319-323
35. Masuda K, Okamoto Y, Tsuura Yet al. (1995) Effects of troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide. Diabetologia 38: 24-30
36. Katz AM (1977) Physiology of the heart. Raven, New York
37. Shimabukuro M, Shinzato T, Higa S et al. (1995) Long-term troglitazone treatment preserves cardiac function of streptozotocin-induced diabetic rat. Diabetes 44 [Suppl 1]: 797 (Abstract)
38. Kraegen EW, Sowden JA, Halstead MB et al. (1993) Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin stimulation and immunoisolation studies of Glut1 and Glut4. Biochem J 295: 287-293
39. Uphues I, Kolter T, Goud B, Eckel J (1995) Failure of insulin-regulated recruitment of the glucose transporter GLUT4 in cardiac muscle of obese Zucker rats is associated with alterations of small-molecular-mass GTP-binding proteins. Biochem J 311: 161-166
40. Garvey WT, Hardin D, Juhaszova M, Dominguez JH (1993) Effects of diabetes on myocardial glucose transport system in rat: implications for diabetic cardiomyopathy. Am J Physiol 264: H837-H844